Delivery Order SPE2DB20D1109-SPE2DB25FP46M
- Not listed
- The Defense Logistics Agency awarded a $4,310.34 delivery order to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100-count units) under a firm fixed price contract. This delivery order, issued on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a small-value transaction for pharmaceutical supply to support federal medical procurement needs. The award was made on a non-set-aside, competitive basis, with performance occurring at the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Progesterone 200 mg capsules in quantities of 100 units, with a ceiling value of $1,519.84. This firm fixed price delivery order, which is not set-aside designated, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Progesterone 200 mg capsules in quantities of 100 units, with a ceiling value of $8,677.17 and a firm fixed price structure. This non-set-aside award is classified as a delivery order and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $9,242.11 to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $14,740.75 to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed price delivery order represents a non-competitive set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,720.92 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units). This firm fixed-price contract, awarded on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a non-competitive set-aside delivery order. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The award falls under the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 100-count capsules of 200 mg progesterone. The $5,944.59 firm fixed-price contract has a completion date of June 18, 2025. Amerisourcebergen is not subject to any set-aside requirements for this award. The company holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 capsules of 200 mg progesterone, a pharmaceutical product, with a ceiling value of $11,391.68 and a period of performance through February 27, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $27,245.19 delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery order, with performance to be executed at the awardee's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, to supply 4,565,940,454 units of the drug Progesterone 200 mg capsules. The $2,346.24 contract has a completion date of September 26, 2024 and is not a set-aside award. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through 2025,...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP46MDelivery Order
The Defense Logistics Agency awarded a $5,503.81 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Progesterone 200 mg, with an ultimate completion date of July 28, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery order falls within AmerisourceBergen's established relationship with DLA as a critical vendor for federal medical procurement. The company holds a $999.9 billion IDC with DLA Troop Support Medical (SPE2DX) extending through December 2026, which serves as the parent contract vehicle enabling the supply of pharmaceuticals and medical commodities to support military healthcare systems globally. AmerisourceBergen's federal contract portfolio demonstrates consistent capability in competitively awarded pharmaceutical distribution across multiple therapeutic domains, including specialty medications, vaccines, and medical supplies serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 7/26/25 |